Evidence map›Paper›PMID 40852743›Full record

ArticleEuropean journal of rheumatology2025

Interstitial Lung Disease Associated with Autoimmune Rheumatic Diseases: An Experience from Türkiye.

Cemal Bes, Fatih Yildirim, Ramazan Eren, Şerife Ulusan, Rabia Deniz, Bilgin Karaalioglu, Duygu Sevinç Ozgur, Gamze Akkuzu, Barış Demirkol, Mustafa Kağan Erener and 2 more

Abstract read
In one paragraph

Article in European journal of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cemal BesDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID 0000-0002-1730-2991
Fatih YildirimDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID 0000-0003-3909-7500
Ramazan ErenDepartment of Chest Disease, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Türkiye.
Şerife UlusanDepartment of Radiology, Acibadem University, Bodrum Hospital, İzmir, Türkiye.ORCID 0000-0003-1994-9307
Rabia DenizDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID 0000-0003-4537-894X
Bilgin KaraaliogluDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID 0000-0001-7584-8549
Duygu Sevinç OzgurDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID 0000-0002-1294-926X
Gamze AkkuzuDepartment of Rheumatology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID 0000-0002-2133-0282
Barış DemirkolDepartment of Chest Disease, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.ORCID 0000-0001-5585-3842
Mustafa Kağan ErenerUndergraduate, University of Health Sciences, Hamidiye International School of Medicine, İstanbul, Türkiye.ORCID 0000-0002-1195-3099
Melek Yalçın MutluDepartment of Internal Medicine, Rheumatology and Immunology, Friedrich-Alexander University Erlangen- Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.ORCID 0000-0003-0598-5737
Erdoğan ÇetinkayaDepartment of Chest Disease, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Türkiye.ORCID 0000-0002-0891-0020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Interstitial lung disease (ILD) is one of the most challenging involvement of autoimmune rheumatic diseases (ARDs) and could lead to significant morbidity and mortality. In this article, a collaborative work of tertiary rheumatology and pulmonology centers describing demographic, serological, and radiological findings of patients with ARD associated with ILD (ARD-ILD) is presented. Methods: A descriptive, retrospective study, and data related to demographics, clinical, laboratory, radiologic, or histopathological findings of ILD were collected from the study participants' charts. Results: Around 212 patients with ARD-ILD were evaluated. Of the patients, 172 (81.1%) were female and 40 (18.9%) were male. The distribution of the rheumatic diseases was as follows: systemic sclerosis in 114 (53.8%), rheumatoid arthritis in 47 (22.2%), Sjögren's syndrome in 14 (6.6%), inflammatory myopathy in 16 (7.5%) patients, interstitial pneumonia with autoimmune features (IPAF) in 9 (4%) patients, undifferentiated connective tissue disease in 8 (3.8%), and systemic lupus erythematosus in 4 (1.9%). According to the radiological patterns, 71.7% of the patients had nonspecific interstitial pneumonia (NSIP), 13.7% had definite usual interstitial pneumonia (UIP), 8.5% had probable UIP, 3.8% had lymphocytic interstitial pneumonia, 1.9% had organizing pneumonia, and 0.5% had an atypical pattern. Conclusion: This study showed that the most common rheumatic disease causing ILD is still systemic sclerosis, and NSIP is more prominent as a radiological pattern. IPAF, a disease that has entered the literature in recent years, is also an important type of ILD. Given the multisystemic involvement of ARDs, collaboration among different disciplines is undoubtedly crucial in the diagnosis and management of these diseases.

Identifiers

PMID40852743
PMCPMC12362481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.